| Long noncoding RNA RC3H2 facilitates cell proliferation and invasion by targeting MicroRNA-101-3p/EZH2 axis in OSCC K Wu, Y Jiang, W Zhou, B Zhang, Y Li, F Xie, J Zhang, X Wang, M Yan, ... Molecular Therapy-Nucleic Acids 20, 97-110, 2020 | 77 | 2020 |
| Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data Z Liu, W Zhou, C Lin, X Wang, X Zhang, Y Zhang, R Yang, W Chen, ... Aging (Albany NY) 13 (2), 2379, 2020 | 21 | 2020 |
| Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation W Zhou, Y Feng, C Lin, CK Chao, Z He, S Zhao, J Xue, XY Zhao, W Cao Advanced Science 10 (25), 2207549, 2023 | 15 | 2023 |
| Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance X Lin, W Zhou, Z Liu, W Cao, C Lin Oral Diseases 29 (8), 3101-3120, 2023 | 10 | 2023 |
| Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma Z Liu, Z Zhang, Y Zhang, W Zhou, X Zhang, C Peng, T Ji, X Zou, Z Zhang, ... International Journal of Oral Science 16 (1), 9, 2024 | 9 | 2024 |
| A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma W Zhou, C Peng, Z Liu, W Cao European Archives of Oto-Rhino-Laryngology, 1-8, 2022 | 8 | 2022 |
| Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression … X Li, Z Liu, W Zhou, X Liu, W Cao BMC cancer 21, 1-13, 2021 | 7 | 2021 |
| The CC ligand chemokine family members CCL17/CCL22 predict the survival and response to immune checkpoint blockade therapy of patients with head and neck squamous cell carcinoma W Zhou, X Zhang, Y Feng, Y Zhang, Z Liu Current Problems in Cancer 46 (6), 100896, 2022 | 3 | 2022 |
| CBX3 is a prognostic biomarker correlated with ATR activation and immune infiltration in head and neck squamous cell carcinoma X Zhang, W Zhou, Y Zhang, Z Liu International Journal of General Medicine, 1497-1508, 2022 | 3 | 2022 |
| CCL17/CCL22 Predict the Survival and Response to Immune Checkpoint Blockade Therapy of Patients with HNSCC W Zhou, X Zhang, Y Long, X Lin, Y Zhang, Z Liu | | 2021 |
| Downregulation of CCL22 and Mutation of NOTCH1 in Tongue Squamous Cell Carcinoma Decreases Th2 Cell Recruitment and Expression to Predict Poor Clinical Outcomes X Li, Z Liu, W Zhou, W Cao, X Liu | | 2021 |
